VEGFC and infarction: At the time we injected sr39HSV1tk-MSCs (1 week after infarction), cardiomyocytes around the newly forming scar are known to express high levels of vascular endothelial growth factor (VEGF)-C [39], which may facilitate the differentiation of sr39HSV1tk-MSCs into lymphatic endothelium.